Trials / Sponsors / Actuate Therapeutics Inc.
Actuate Therapeutics Inc.
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Withdrawn | 9-ING-41 Plus Carboplatin in Patients With Advanced, Metastatic Salivary Gland Carcinoma Salivary Gland Carcinoma, Adenoid Cystic Carcinoma, Salivary Gland Cancer | Phase 2 | 2030-12-18 |
| Completed | Actuate 1901: 9-ING-41 in Myelofibrosis Myelofibrosis | Phase 2 | 2020-08-20 |
| Terminated | 9-ING-41 in Pediatric Patients With Refractory Malignancies. Refractory Cancer, Refractory Neoplasm, Cancer Pediatric | Phase 1 | 2020-06-05 |
| Active Not Recruiting | 9-ING-41 in Patients With Advanced Cancers Cancer, Pancreatic Cancer, Sarcoma | Phase 2 | 2019-01-04 |